Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey
JOURNAL OF THORACIC ONCOLOGY, vol.13, no.10, 2018 (SCI-Expanded)
- Publication Type: Article / Abstract
- Volume: 13 Issue: 10
- Publication Date: 2018
- Journal Name: JOURNAL OF THORACIC ONCOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Keywords: NSCLC, ALK inhibitor, crizotinib
- Akdeniz University Affiliated: Yes